World Congress on Industrial Biotechnology and Bioprocessing To Highlight Pharmaceutical Production

WASHINGTON, D.C. (Thursday, March 27, 2008) - The World Congress on Industrial Biotechnology and Bioprocessing will explore industrial biotechnology’s potential for cleaner, low-cost production of pharmaceutical and nutraceutical ingredients. Enzymatic and fermentation systems can produce purer products from renewable resources with less waste and energy.


                        “We’re bringing together leaders from industrial biotechnology and biopharmaceuticals to discuss issues such as scientific innovation, market growth, policy developments and future trends related to industrial biotech’s potential for the pharmaceutical industry,” said Brent Erickson, executive vice president of the Industrial and Environmental Section at BIO. “Forums such as this are critical for engaging in a dialogue that will ultimately serve to move innovation forward.”


Below are sessions focused on biopharmaceuticals and nutraceuticals:


New Sources of Biopharmaceuticals

  • Yi Tang, University of California, Los Angeles – Biocatalysis for Simvastatin Production
  • Karen McDonald, University of California, Davis -- A Plant-Based System for Rapid, Large-Scale Production of Biopharmaceuticals
  • Ivonne Naumann, Institute of Bioprocess Engineering -- Marine Drug Discovery


Biotech in Big Pharma - 'Red Biotech'

  • Mahmoud Mahmoudian, Merck USA
  • Steven Projan, Wyeth Research -- Drug Discovery & Development in the 21st Century
  • Steve Farrand, Schering-Plough USA

  • Robert Ryall, sanofi pasteur -- Biotechnology Advances in Influenza Vaccine Production


Production of Nutraceutical Ingredients Using White Biotechnology Processes

  • Jochen Forster, Fluxome Sciences A/S
  • Hans-Peter Meyer, LONZA -- Examples of Bioprocesses for Nutraceutical Production
  • Michael Katz, Fluxome Sciences A/S -- Engineering Microbes for Resveratrol Production
  • Volkert Claassen, DSM -- White Biotechnology Challenges and Opportunities
  • Herbert Woolf, HDW Consulting -- White Biotechnology for Riboflavin Production


The event will also feature an exhibit hall, business partnering and networking opportunities, and a poster reception.


The 2008 World Congress on Industrial Biotechnology and Bioprocessing will be co-hosted by the American Chemical Society, and the National Agricultural Biotechnology Council with support from BIOTECanada.


Advance media registration is available online through April 22, 2008, and is complimentary for credentialed members of the news media.   To register, please visit:


For more information on the 2008 World Congress on Industrial Biotechnology and Bioprocessing, please visit the conference webpage at


The World Congress is the only global conference dedicated solely to the most recent advancements in industrial biotechnology.



Upcoming BIO Events

 ·   BIO-Europe Spring 
    April 7-9, 2008
    Madrid, Spain

 ·   BIO National Venture Conference 
    April 22-23, 2008
    Boston, Mass.

 ·   World Congress on Industrial Biotechnology & Bioprocessing  
    April 27-30, 2008
    Chicago, Ill.

 ·   2008 BIO International Convention 
    June 17-20, 2008
    San Diego, Calif.


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.